Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Rifampin in Rhinoscleroma
NCT05431673Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of doxycycline in Rhinoscleroma (3 arms), sponsored by Assiut University. Primary endpoint: Percentage of patients showing post treatment histopathologic resolution at 8 months. Status: unknown.
02
Drugs
doxycycline
03
Conditions
Rhinoscleroma
Beyond the preview
Go deeper on NCT05431673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05431673.